A long time ago, Atlanta's mostly white business elite and the mostly black political leadership decided to be pragmatic. They crafted a kind of civic peace treaty known as "the Atlanta way" that allowed commerce to thrive and the city to grow, all the while maintaining peaceful race relations that tagged Atlanta as "the city too busy to hate."
Not everyone views the relationship as being mutually beneficial, but the results are hard to dispute. From the poorest region of the country, my hometown emerged as a modern capital, an international corporate hub, and the host of the Olympic Games. The one problem that "the Atlanta way" could not fix, at least until this week, was the disaster known as Grady Memorial Hospital.
On Monday, Grady's new nonprofit board of directors hired Michael Young, CEO of Erie County Medical Center, becoming the sixth Grady CEO since 2005. There is reason to hope that Young—a proven turnaround leader—will finally be the one to save Grady from itself.
On the same day Young was hired, the board reportedly paid the fifth CEO since 2005, state legislator Pam Stephenson, $325,000 to leave after six months of work, for which, as the Atlanta-Journal Constitution adds, "she had no real qualifications for in the first place." Her departure also ended questions over her original two-year contract, which was approved by the previous board, which she just happened to chair.
There is reason to hope that the politics that have been the root of disease at Grady for so long are in the past. The new 17-member nonprofit board is full of heavyweights, including A.D. "Pete" Correll, chairman emeritus of Georgia Pacific; Dr. Louis Sullivan, the former secretary of Health and Human Services; Atlanta School Superintendent Beverly Hall, and Cousins Properties CEO Thomas Bell. In addition to their leadership and business skills, the new board has already received commitments for $200 million in donations with the prospect of $100 million more. As with any other city, big-money donors run in elite circles who usually only trust donations to charitable causes within that circle. Up until now, Grady was on the outside.
What I believe is the single differentiator and what gives Young and his new team a fighting chance is that this new board stands to gain nothing from Grady. Questions of politics and conflicts-of-interest should remain in the past.
Will "the Atlanta way" work? The payer mix is still dreadful because the state government generally treats Atlanta's problems as Atlanta's problems when the Medicaid checks are written. Paying customers long ago fled the inner city to hospitals outside the I-285 perimeter.
It's too trite to say Grady can't fail now. You don't turn around decades of decline easily. But at least the city is using some reliable civic tools now to move forward.
Jim Molpus is Editor-in-Chief of HealthLeaders Media. He can be reached at jmolpus@healthleadersmedia.com.
Note: You can sign up to receive HealthLeaders Media Corner Office, a free weekly e-newsletter that reports on key management trends and strategies that affect healthcare CEOs and senior leaders.
A demonstration held in the Connecticut capitol called on Gov. M. Jodi Rell and the state business community to cut the cost and broaden the accessibility of health insurance during the 2009 legislative session. Citizens for Economic Opportunity organized the march with the Connecticut Citizen Action Group as part of a broader, national initiative sponsored by the advocacy group Health Care for America Now. Organizers said they hoped to draw attention to what they called "the need for quality, affordable healthcare for all Americans," according to a release.
Bill Gates and New York City Mayor Michael R. Bloomberg have announced that they would spend $500 million to stop people around the world from smoking. The World Health Organization estimates that tobacco will kill up to a billion people in the 21st century. In an effort to cut that number, Bloomberg's foundation plans to commit $250 million over four years on top of a $125 million gift he announced two years ago, while the Bill and Melinda Gates Foundation is allocating $125 million over five years.
U.S. drug manufacturers are reaping a windfall from taxpayers because Medicare's privately administered prescription drug benefit program pays more than other government programs for the same medicines, according to a report from the House Committee on Oversight and Government Reform. The report found that taxpayers are paying up to 30% more for prescription drugs under Medicare's privatized Part D program for seniors and the disabled than under the government's Medicaid program for the poor. Committee Chairman Henry A. Waxman said he would introduce legislation to guarantee that federal taxpayers would not be charged higher prices under Medicare Part D than under Medicaid.
A recent study showed that eight out of 10 people go online for health information, but only 45% of those Web sites are accurate. So patients are increasingly turning to fellow patients for advice, information, support, or just a laugh through blogs.
A study that linked the heart drug Vytorin to excess cancer deaths has provoked controversy among heart specialists worried that the drug's risks may outweigh its benefits. The study, called SEAS, was designed to test whether Vytorin could prevent severe, age-related heart valve problems by reducing cholesterol. But lead investigator Terje Pedersen of Ulleval University Hospital reported that the study turned up a link to cancer. At that same session, Oxford University experts released a separate analysis comparing SEAS data with two other ongoing studies and concluded that the cancer link was not credible.